Genetic Susceptibility to Listeriosis - Listeria-GEN

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Listeriosis is a rare, severe foodborne infection, responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor. The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae). The aim of the study is to identify genetic susceptibility to Listeriosis.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Microbiologically documented Listeriosis (either a severe form of listeriosis, or an atypical form of listeriosis, or less than 40 years old and without any co-morbidity identified)

• Affiliated or beneficiary of a social security system

• Informed and written consent

• defined as father, mother, brother (s), sister (s), child (ren), grandparent (s), uncle (s), aunt (s), cousin (s), nephew (s), niece (s).

• Affiliated or beneficiary of a social security system

• Informed and written consent

Locations
Other Locations
France
Centre Médical de l'Institut Pasteur
RECRUITING
Paris
Contact Information
Primary
Marc Lecuit
marc.lecuit@pasteur.fr
+33 1 40 61 34 20
Backup
Caroline Charlier-Woerther
caroline.charlier@pasteur.fr
+33 1 40 31 30 10
Time Frame
Start Date: 2017-11-28
Estimated Completion Date: 2027-11-30
Participants
Target number of participants: 100
Treatments
Experimental: Patients with Listeriosis
Patients with Listeriosis.~Human biological samples :~* Blood sample~* Skin biopsy~* Saliva
Experimental: Volunteers related with patients with Listeriosis
Volunteers related with patients with Listeriosis.~Human biological samples :~* Blood sample~* Skin biopsy~* Saliva
Related Therapeutic Areas
Sponsors
Collaborators: Icahn School of Medicine at Mount Sinai
Leads: Institut Pasteur

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.